Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
15.98 Up 0.28(1.78%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Jun 30, 2013Mar 31, 2013Sep 30, 2012
Total Revenue 6   -   -   1  
Cost of Revenue -   -   -   -  
Gross Profit 6   -   -   1  
Operating Expenses
Research Development4,787  6,037  6,308  3,132  
Selling General and Administrative1,215  1,171  1,067  1,452  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,996) (7,208) (7,375) (4,583)
Income from Continuing Operations
Total Other Income/Expenses Net(2)1  1  (1)
Earnings Before Interest And Taxes(5,998)(7,207)(7,374)(4,584)
Interest Expense -   -   -   -  
Income Before Tax(5,998)(7,207)(7,374)(4,584)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,998)(7,207)(7,374)(4,584)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,998) (7,207) (7,374) (4,584)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,998) (7,207) (7,374) (4,584)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.